Dr. Daniel Todd Finn, MD

Dr. Finn practices at South Shore Skin Surgeons in Braintree, Massachusetts.

Dr. Finn's NPI, 1205916020, was assigned on October 16, 2006. Dr. Finn graduated from Perelman School of Medicine - Philadelphia in 1994. Dr. Finn holds Massachusetts license 155146.

Dr. Finn's primary practice is South Shore Skin Surgeons, at 400 Washington St Suite 200 Suite 200, Braintree, MA 02184-4769. The practice phone is (781) 380-8150.

Dr. Finn's primary practice is South Shore Skin Surgeons in Braintree, Massachusetts. The medical group on file is Adult & Pediatric Dermatology, PC. Dmand AI also links Dr. Finn to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finn practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Finn's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Finn is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Finn's licenses on file in 2 states: Massachusetts and Pennsylvania.

CMS data shows 1,752 Medicare services from Dr. Finn across 25 procedure codes in 2024, for 538 Medicare patients. Medicare paid $553,999 for them. Every service was in an office.

CMS counts 538 Medicare patients who saw Dr. Finn in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Finn's median patient age at 76, with 44% women.

In 2024, Dr. Finn wrote 314 Medicare Part D claims for 248 patients. 100% of them were for generic drugs. CMS names the drug for 275 of them, across 5 drugs with 11 or more claims each, at $2,736 in total drug cost. In 2023, CMS named 197 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Finn for performance year 2024, reported individually. Dr. Finn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 140 procedures of melanoma (skin cancer) excision by Dr. Finn, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Finn, published from 2009 to 2013. 2009 was the busiest year, with 2. The most frequent topics are Mohs Surgery, Skin Neoplasms and Carcinoma, Basal Cell. Dr. Finn has published most often in Dermatol Surg. Dr. Finn's most frequent co-authors are Deborah Lynn Cummins, MD, Gary S. Rogers, MD and Gary S. Chuang, MD.

CMS Open Payments shows 1 general payment to Dr. Finn from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $15.

Dmand AI lists 3 awards for Dr. Finn, most recently Fellow in 1999.

Dr. Finn graduated from Perelman School of Medicine - Philadelphia in 1994. Dr. Finn is a member of AAD, ASDS and MMS.

Dr. Finn is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.